Abstract
Objectives. We set out to determine the clinical significance of atypical immature squamous metaplasia (AIM). Methods. We performed in a military, hospital-based coloscopy clinic a descriptive, retrospective review of patients who had a diagnosis of AIM. Patients were examined at 3- to 4-month intervals for at least 1 year after a diagnosis of AIM was established. A gynecological pathologist reviewed all histological and cytological specimens. Initial histological or cytological specimens were tested for the presence of HPV DNA using in situ hybridization. Results. High-risk HPV DNA types 16 or 18 were detected in 3% of patients with AIM. Concurrent cervical intraepithelial neoplasia 3 (CIN3) was noted in 3% of patients with AIM. One-third of patients with initially diagnosed AIM had complete resolution of this lesion after 1 year of follow-up. Conclusions. This descriptive, retrospective review shows that AIM does not appear to be associated with high-risk HPV DNA or with CIN3. In this limited study, a concurrent diagnosis of AIM likely does not influence the 1-year behavior of CIN. The degree of CIN should dictate treatment recommendations. A larger prospective trial is needed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 30-33 |
| Number of pages | 4 |
| Journal | Journal of Lower Genital Tract Disease |
| Volume | 4 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2000 |
Keywords
- Atypical immature squamous metaplasia
- Cervical intraepithelial neoplasia
- Human papillomavirus
ASJC Scopus subject areas
- Obstetrics and Gynecology